Skip to content

Clinical trials

Phase 3 Growth Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Growth Disorders Phase: Phase 3 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20041
20051
20061
20081
20091
20111
20131
20152
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Tampere University3
Ipsen2
Novo Nordisk A/S2
Eli Lilly and Company1
Instituto Nacional de Salud Publica, Mexico1
Johns Hopkins Bloomberg School of Public Health1
Merck KGaA, Darmstadt, Germany1
Northwell Health1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Growth Disorders17
Failure to Thrive4
Malnutrition3
Acromegaly1
Anemia1
Anemia, Iron-Deficiency1
Dwarfism1
Dwarfism, Pituitary1
Fetal Growth Retardation1
Gigantism1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.